Drug for fungal infections in lung transplant recipients increases risk for cancer
Researchers recommend physicians consider patient-specific factors when using voriconazole
04-Sep-2015 -
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UC San Francisco researchers. The team recommends physicians consider patient-specific factors ...
Aspergillus
fungal infections
lung transplants